Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

Autor: Sean J. Barbour, Mark Canney, Rosanna Coppo, Hong Zhang, Zhi-Hong Liu, Yusuke Suzuki, Keiichi Matsuzaki, Ritsuko Katafuchi, Dilshani Induruwage, Lee Er, Heather N. Reich, John Feehally, Jonathan Barratt, Daniel C. Cattran, M.L. Russo, S. Troyanov, H.T. Cook, I. Roberts, V. Tesar, D. Maixnerova, S. Lundberg, L. Gesualdo, F. Emma, L. Fuiano, G. Beltrame, C. Rollino, A. Amore, R. Camilla, L. Peruzzi, M. Praga, S. Feriozzi, R. Polci, G. Segoloni, L. Colla, A. Pani, D. Piras, A. Angioi, G. Cancarini, S. Ravera, M. Durlik, E. Moggia, J. Ballarin, S. Di Giulio, F. Pugliese, I. Serriello, Y. Caliskan, M. Sever, I. Kilicaslan, F. Locatelli, L. Del Vecchio, J.F.M. Wetzels, H. Peters, U. Berg, F. Carvalho, A.C. da Costa Ferreira, M. Maggio, A. Wiecek, M. Ots-Rosenberg, R. Magistroni, R. Topaloglu, Y. Bilginer, M. D’Amico, M. Stangou, F. Giacchino, D. Goumenos, P. Kalliakmani, M. Gerolymos, K. Galesic, C. Geddes, K. Siamopoulos, O. Balafa, M. Galliani, P. Stratta, M. Quaglia, R. Bergia, R. Cravero, M. Salvadori, L. Cirami, B. Fellstrom, H. Kloster Smerud, F. Ferrario, T. Stellato, J. Egido, C. Martin, J. Floege, F. Eitner, A. Lupo, P. Bernich, P. Menè, M. Morosetti, C. van Kooten, T. Rabelink, M.E.J. Reinders, J.M. Boria Grinyo, S. Cusinato, L. Benozzi, S. Savoldi, C. Licata, M. Mizerska-Wasiak, G. Martina, A. Messuerotti, A. Dal Canton, C. Esposito, C. Migotto, G. Triolo, F. Mariano, C. Pozzi, R. Boero, S. Bellur, G. Mazzucco, C. Giannakakis, E. Honsova, B. Sundelin, A.M. Di Palma, E. Gutiérrez, A.M. Asunis, J. Barratt, R. Tardanico, A. Perkowska-Ptasinska, J. Arce Terroba, M. Fortunato, A. Pantzaki, Y. Ozluk, E. Steenbergen, M. Soderberg, Z. Riispere, L. Furci, D. Orhan, D. Kipgen, D. Casartelli, D. Galesic Ljubanovic, H. Gakiopoulou, E. Bertoni, P. Cannata Ortiz, H. Karkoszka, H.J. Groene, A. Stoppacciaro, I. Bajema, J. Bruijn, X. Fulladosa Oliveras, J. Maldyk, E. Ioachim, N. Bavbek, T. Cook, C. Alpers, F. Berthoux, S. Bonsib, V. D’Agati, G. D’Amico, S. Emancipator, F. Emmal, F. Fervenza, S. Florquin, A. Fogo, H. Groene, M. Haas, P. Hill, R. Hogg, S. Hsu, T. Hunley, M. Hladunewich, C. Jennette, K. Joh, B. Julian, T. Kawamura, F. Lai, C. Leung, L. Li, P. Li, Z. Liu, A. Massat, B. Mackinnon, S. Mezzano, F. Schena, Y. Tomino, P. Walker, H. Wang, J. Weening, N. Yoshikawa N, C.-H. Zeng, S. Shi, C. Nogi, H. Suzuki, K. Koike, K. Hirano, T. Yokoo, M. Hanai, K. Fukami, K. Takahashi, Y. Yuzawa, M. Niwa, Y. Yasuda, S. Maruyama, D. Ichikawa, T. Suzuki, S. Shirai, A. Fukuda, S. Fujimoto, H. Trimarchi

Publikováno v: Kidney international, 98(4), 1009-1019. Nature Publishing Group
Kidney International, 98, 4, pp. 1009-1019
Kidney International, 98, 1009-1019

Contains fulltext : 225968.pdf (Publisher’s version ) (Closed access) Immunosuppression in IgA nephropathy (IgAN) should be reserved for patients at high-risk of disease progression, which KDIGO guidelines determine based solely on proteinuria 1g o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a30eea7fd7489265252419d233f2e8e8
https://pure.amc.nl/en/publications/improving-treatment-decisions-using-personalized-risk-assessment-from-the-international-iga-nephropathy-prediction-tool(d812809c-0a7b-4a59-a449-e693d5ed0f19).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Premier épisode de rejet aigu après transplantation rénale : étude des caractéristiques histopathologiques en fonction du risque immunologique du patient

Autor: Bruno Bourgeon, Nacera Ouali, Philippe Lang, François Bayle, Daniel Abramowicz, Patrick Peeters, Georges Mourad, Renaud Snanoudj, Christophe Legendre, Gérard Rifle, David Buob, Dominique Durand, Guy Touchard, Christian Noel, F. Berthoux, Michèle Kessler, Lidia Ghisdal, Michel Delahousse, Pierre Merville, Jean-Paul Squifflet, Bernard Bourbigot, Jean-Michel Goujon

Publikováno v: Néphrologie & Thérapeutique. 4:173-180

Summary Renal allograft biopsies ( n = 34) of two different populations of patients according to the immunological risk (high versus low-risk) have been compared retrospectively. The presence of polymorphonuclear leukocytes in peritubular capillaries

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::955a38db7a7fb716f2bc2ab275a88fe8
https://doi.org/10.1016/j.nephro.2008.02.001

Characteristics of IgA and Macromolecular IgA in Sera from IgA Nephropathy Transplanted Patients with and without IgAN Recurrence

Autor: R. Coppo, A. Amore, P. Cirina, M. Messina, B. Basolo, G. Segoloni, F. Berthoux, R. Boulahrouz, J. Egido, R. Alcazar, A. R. Clarkson, A. J. Woodroffe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5105c0b6bce4037fb6bf78a1e2fb01ee
https://doi.org/10.1159/000423881

CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: The 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis

Autor: M.-T. Linossier, F. Berthoux, Christophe Mariat, L. Thibaudin, A. Afiani, P. Berthoux

Publikováno v: Kidney International. 69:565-572

The chemokine (CK) receptor 5 (CCR5) is necessary for two adjacent cysteines (CC)-CKs such as Regulated upon Activation Normal T cell Expressed and Secreted, a/o Macrophage Inflammatory Protein 1 α / β to mediate their inflammatory properties. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87018278588a68afde27a5bd39519353
https://doi.org/10.1038/sj.ki.5000106